Avoro Capital Advisors LLC 13D and 13G filings for MoonLake Immunotherapeutics:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 09:03 am Sale | 2025-09-30 | 13G | MoonLake Immunotherapeutics MLTX | Avoro Capital Advisors LLC | 2,000,000 3.150% | -2,150,000 (-51.81%) | Filing |
| 2025-08-14 06:57 am Purchase | 2025-06-30 | 13G | MoonLake Immunotherapeutics MLTX | Avoro Capital Advisors LLC | 4,150,000 6.500% | 4,150,000 (New Position) | Filing |